Intervention Review

Methenamine hippurate for preventing urinary tract infections

  1. Bon San B Lee1,*,
  2. Tushar Bhuta2,
  3. Judy M Simpson3,
  4. Jonathan C Craig3,4

Editorial Group: Cochrane Renal Group

Published Online: 17 OCT 2012

Assessed as up-to-date: 7 JUN 2012

DOI: 10.1002/14651858.CD003265.pub3

How to Cite

Lee BSB, Bhuta T, Simpson JM, Craig JC. Methenamine hippurate for preventing urinary tract infections. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD003265. DOI: 10.1002/14651858.CD003265.pub3.

Author Information

  1. 1

    Prince of Wales Hospital, Spinal Medicine Department, Randwick, NSW, Australia

  2. 2

    Royal North Shore Hospital, Department of Neonatal Medicine, Sydney, New South Wales, Australia

  3. 3

    The University of Sydney, Sydney School of Public Health, Sydney, NSW, Australia

  4. 4

    The Children's Hospital at Westmead, Cochrane Renal Group, Centre for Kidney Research, Westmead, NSW, Australia

*Bon San B Lee, Spinal Medicine Department, Prince of Wales Hospital, Level 2, High St Entrance, Randwick, NSW, 2031, Australia.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 17 OCT 2012


Cited in:


This article has been cited by:

  1. 1
    Lindsay E. Nicolle, Catheter-Related Urinary Tract Infection: Practical Management in the Elderly, Drugs & Aging, 2014, 31, 1, 1


  2. 2
    Suzanne E. Geerlings, Mariëlle A.J. Beerepoot, Jan M. Prins, Prevention of Recurrent Urinary Tract Infections in Women, Infectious Disease Clinics of North America, 2014, 28, 1, 135


  3. 3
    Amanda Kay Shepherd, Paul S. Pottinger, Management of Urinary Tract Infections in the Era of Increasing Antimicrobial Resistance, Medical Clinics of North America, 2013, 97, 4, 737